Medexus Pharmaceuticals Inc.

Medexus Pharmaceuticals is a specialty pharmaceutical company with a robust North American commercial platform. The company focuses on the licensing, acquisition, and commercialization of innovative, high-value orphan and rare disease treatment solutions, rather than internal drug discovery. Medexus operates through two primary segments, Medexus Pharma Canada and Medexus Pharma USA, with a therapeutic focus on hematology, hematology-oncology, rheumatology, allergy, and dermatology. The company leverages an integrated infrastructure including regulatory, medical affairs, and salesforce capabilities to bring specialty products to market.